Excellent survival of pathological N0 small cell lung cancer patients following surgery
Abstract Background Current clinical guidelines recommend surgery only for cT1-2N0M0 small cell lung cancer (SCLC) patients. In light of recent studies, the role of surgery in the treatment of SCLC needs to be reconsidered. Methods We reviewed all SCLC patients who underwent surgery from November 20...
Main Authors: | Zichen Fu, Di Li, Chaoqiang Deng, Jingshun Zhang, Jinsong Bai, Yuan Li, Haiquan Chen, Yang Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-023-01044-3 |
Similar Items
-
Long-term results of postoperative unsuspected small cell lung cancer on real-world data
by: Juntang Guo, et al.
Published: (2022-12-01) -
Platelet–lymphocyte ratio is a prognostic marker in small cell lung cancer—A systemic review and meta-analysis
by: Hongbin Zhou, et al.
Published: (2023-01-01) -
Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer
by: Xinyu Fan, et al.
Published: (2023-06-01) -
Impact of Lung Metastasis versus Metastasis of Bone, Brain, or Liver on Overall Survival and Thyroid Cancer-Specific Survival of Thyroid Cancer Patients: A Population-Based Study
by: Miaochun Zhong, et al.
Published: (2022-06-01) -
Comparison of oral versus intravenous etoposide in the management of small‐cell lung cancer; A real‐world, population‐based study
by: Hatim Karachiwala, et al.
Published: (2021-01-01)